Comparing breathing techniques for COPD management
Comparative Effects of BBT and Active Cycle of Breathing Technique on Dyspnea and Quality of Life in COPD
This study is testing whether two different breathing techniques can help people with COPD breathe easier and feel better in their daily lives.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 50 Years to 70 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Lahore, Punjab) |
| Trial ID | NCT05947253 on ClinicalTrials.gov |
What this trial studies
This study compares the effects of the Buteyko breathing technique and the Active Cycle of Breathing Technique on dyspnea and quality of life in patients with chronic obstructive pulmonary disease (COPD). It aims to improve breathing patterns and alleviate symptoms by retraining the body's breathing through these techniques. A total of 40 participants will be randomly assigned to either the Buteyko group or the Active Cycle group, with each group undergoing daily sessions lasting 30 to 35 minutes. The study will assess improvements in breathing difficulty and overall quality of life.
Who should consider this trial
Good fit: Ideal candidates are adults diagnosed with COPD who are hemodynamically stable and capable of completing the IPAQ questionnaire.
Not a fit: Patients with unstable cardiac disease, significant orthopedic issues, or resting oxygen saturation below 90% are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide patients with COPD effective non-pharmacological methods to manage their symptoms and improve their quality of life.
How similar studies have performed: While there is limited research on the Buteyko technique specifically for COPD, similar breathing techniques have shown promise in managing respiratory conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of COPD confirmed by smoking history. * PFT showing irreversible airflow limitation. * Patients hemodynamically stable. * Males and females. * Patients capable of completing IPAQ questionnaire Exclusion Criteria: * Evidence of unstable cardiac disease, Pulmonale decompensation * Disabling diseases which prevented participation in the exercise program, such as orthopedic inabilities or peripheral vascular disease. * Systemic illness. * Resting O2 saturation \<90% with room air breathing and Patient with viral infection
Where this trial is running
Lahore, Punjab
- Pulmonary ward Jinnah hospital Lahore. — Lahore, Punjab, Pakistan (Recruiting)
Study contacts
- Principal investigator: Sidra Faisal, MS.CPPT — Riphah International University
- Study coordinator: Iqbal Tariq, PHD
- Email: iqbal.tariq@riphah.edu.pk
- Phone: O3338236752
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.